Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Domain leads aTyr Pharma's $23mm Series C round

Executive Summary

Domain Associates has led aTyr Pharma Inc.'s $23mm oversubscribed Series C venture round and will contribute one board member. It joins current shareholders Alta Partners, Cardinal Partners, and Polaris Ventures. The company will use the proceeds to continue developing its preclinical pipeline and move physiocrine drug candidates--which have potential to treat patients with blood, immune, and metabolic disorders--into clinical studies. ATyr Pharma has raised $46mm to date.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

UsernamePublicRestriction

Register